Selective serotonin reuptake inhibitors for premenstrual syndrome and premenstrual dysphoric disorder-Reference-Cited by-同舟云学术

Selective serotonin reuptake inhibitors for premenstrual syndrome and premenstrual dysphoric disorder

Published:2024-08-14 Issue:8 Volume:2024 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Jespersen Cecilie¹²,Lauritsen Mette Petri³⁴,Frokjaer Vibe G⁵⁶,Schroll Jeppe B¹²⁷

Affiliation:

1. Centre for Evidence-Based Medicine Odense (CEBMO) and Cochrane Denmark; Department of Clinical Research, University of Southern Denmark; Odense Denmark

2. Open Patient data Explorative Network (OPEN); Odense University Hospital; Odense Denmark

3. Department of Obstetrics and Gynaecology; Odense University Hospital; Odense Denmark

4. Faculty of Health Sciences; University of Copenhagen; Copenhagen Denmark

5. Neurobiology Research Unit, Department of Neurology; Rigshospitalet Copenhagen University Hospital; Copenhagen Denmark

6. Mental Health Services; Capital Region of Copenhagen; Brondby Denmark

7. Department of Gynecology and Obstetrics; Copenhagen University Hospital; Herlev Denmark

Publisher

Wiley

Reference160 articles.

1. Relationship and response of food cravings and depression to sertraline in patients with premenstrual syndrome;Arredondo-Soberon;Fertility and Sterility,1997

2. Efficacy of intermittent fluoxetine dosing in premenstrual dysphoric disorder (PMDD);Cohen;European Neuropsychopharmacology,2001

3. Premenstrual daily fluoxetine for premenstrual dysphoric disorder: a placebo controlled, clinical trial using computerized diaries;Cohen;Obstetrics and Gynecology,2002

4. Intermittent fluoxetine dosing in premenstrual dysphoric syndrome;Judge;World Journal of Biological Psychiatry,2001

5. Predictors of response to luteal phase fluoxetine treatment of PMDD;Miner;International Journal of Neuropsychopharmacology,2002